Compare StocksABBV vs ALL

AbbVie Inc. (ABBV) vs The Allstate Corporation (ALL): Which Is the Better Buy in 2026?

As of 2026-08-03, ABBV is overvalued at $251, with a DCF intrinsic value of $178 and a margin of safety of -41%. ALL is undervalued at $264, with an intrinsic value of $618 and a margin of safety of 57%. Of the two, ALL has the wider margin of safety.

ABBV
AbbVie Inc.
$250.94
VS
ALL
The Allstate Corporation
$264.08

Rewards

ABBV
  • AbbVie Inc. has maintained ROIC above 10% for 4 consecutive years, suggesting solid business economics.
  • Gross margin of 72.8% indicates strong pricing power — typical of businesses with significant intellectual property or brand strength.
  • AbbVie Inc. scores 82/100 on the Economic Moat Score (Wide Moat), with reinvestment efficiency as the strongest competitive dimension.
ALL
  • The Allstate Corporation scores 97/100 on the Economic Moat Score (Wide Moat), with revenue predictability as the strongest competitive dimension.
  • Free cash flow has grown at a 28.1% CAGR over the past 4 years, demonstrating strong earnings power growth.
  • Each dollar of retained earnings has created $11.02 of earning power — management is an exceptional capital allocator.

Risks

ABBV
  • Buybacks have been poorly timed — 3 out of 4 years involved repurchases at relatively expensive valuations.
  • Free cash flow has declined at a 9.8% CAGR over the past 4 years — a concerning trend.
ALL
  • PEG ratio of 3.16 indicates the stock is expensive relative to its expected growth — the market may be pricing in more growth than analysts project.
  • Altman Z-Score of 1.65 places the company in the distress zone — financial patterns resemble those of companies that experienced bankruptcy.
  • 23 insider sales with no purchases over the past 12 months — a persistent pattern of insider selling.

Key Valuation Metrics

Learn more →
ABBV
ALL
Valuation
N/A
Free Cash Flow
$12.43B
N/A
FCF Yield
18.28%
70.89
Trailing P/E
5.84
15.41
Forward P/E
9.96
Quality & Moat
27.60%
ROIC
26.12%
N/A
ROE
45.22%
72.79%
Gross Margin
34.43%
0.41
PEG Ratio
3.16
Balance Sheet Safety
N/A
Net Debt / Equity
0.07
N/A
Interest Coverage
N/A
2.06
Net Debt / EBITDA
0.14
2.76%
Dividend Yield
1.64%
ABBV: 4Ties: 1ALL: 3
ABBVALL

Historical Fundamentals

Learn more →
ABBV

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

ALL

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

$1 Retained Earnings Test

Learn more →
ABBV
N/A
Net losses over 3 years — test not applicable
Company had negative cumulative retained earnings
Σ Retained
$-19.85B
Δ Market Cap
+$118.02B
Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer
ALL
$1.61
created per $1 retained over 3 years
Value Creator
Σ Retained
$11.50B
Δ Market Cap
+$18.48B
Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

Discounted Cash Flow (DCF) Analysis

Learn more →
ABBV
40.7% Overvalued
Price is 40.7% above estimated fair value
Current Price: $250.94
Fair Value: $178.31
Strongly undervalued
Undervalued
Fairly valued
Overvalued
Strongly overvalued
ALL
57.3% Margin of Safety
Price is 57.3% below estimated fair value
Current Price: $264.08
Fair Value: $618.46
Strongly undervalued
Undervalued
Fairly valued
Overvalued
Strongly overvalued

Reverse DCF — Market-Implied Growth

Learn more →
ABBV

Requires positive FCF to compute implied growth rate.

ALL

What growth rate is the market pricing in at $264?

-7.8%
Market-Implied Owner Earnings Growth
Standard FCF implies -10.3%

The market implies -7.8% Owner Earnings growth, below historical trends — potential opportunity.

Standard FCF implies a more demanding -10.3%, reflecting heavy growth investment expected to generate future returns.

Economic Moat Score

Learn more →
ABBV
82/100
Wide Moat
70+ Wide · 40-69 Narrow · <40 None

Wide moat with strength across all dimensions. Reinvestment Efficiency is the standout factor.

Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 4 years of fundamental data.
ALL
97/100
Wide Moat
70+ Wide · 40-69 Narrow · <40 None

Wide moat driven primarily by revenue predictability. Margin Stability is the area most vulnerable to competitive pressure.

Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 4 years of fundamental data.

Forensic Accounting

Learn more →
ABBV
-2.86
Unlikely Manipulator
Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone

M-Score Trend

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.
ALL
-2.40
Unlikely Manipulator
Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone
Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

Ownership Breakdown

Learn more →
ABBV
Insiders 0.1%Institutions 76.9%Retail & Other 23.0%
No. of Institutional Holders5,146
High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.
ALL
Insiders 0.5%Institutions 85.6%Retail & Other 13.9%
No. of Institutional Holders2,200
High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.

High insider ownership aligns management incentives with shareholders. Institutional concentration can indicate smart-money conviction but also crowding risk.

Insider Buying Activity

Learn more →
ABBV
0
Buys (3M)
0
Buys (12M)
No open market insider purchases found.
Open market purchases · includes direct & indirect ownership · excludes option exercises
ALL
0
Buys (3M)
0
Buys (12M)
No open market insider purchases found.
Open market purchases · includes direct & indirect ownership · excludes option exercises

Open market purchases · includes direct & indirect ownership · excludes option exercises.

Insider Selling Activity

Learn more →
ABBV
0
Sells (3M)
5
Sells (12M)
Total value (12M): $21.79M
PURDUE DAVID RYAN
Officer
$1.22M
@ $233.56 · 2026-03-04
SIATIS PERRY C.
General Counsel
$4.38M
@ $234.39 · 2026-03-02
SIATIS PERRY C.
General Counsel
$5.15M
@ $230.00 · 2026-02-25
SALEKI-GERHARDT AZITA
Chief Operating Officer
$8.41M
@ $198.42 · 2025-08-12
DONOGHOE NICHOLAS
Officer
$2.64M
@ $198.51 · 2025-08-05
STEWART JEFFREY RYAN
Officer
$12.36M
@ $210.08 · 2025-03-31
REENTS SCOTT T.
Chief Financial Officer
$3.75M
@ $212.34 · 2025-03-14
SIATIS PERRY C.
General Counsel
$5.82M
@ $208.69 · 2025-03-03
GONZALEZ RICHARD A
Director
$20.26M
@ $205.45 · 2025-03-03
RICHMOND TIMOTHY J
Officer
$4.47M
@ $210.45 · 2025-03-03
BUCKBEE KEVIN K
Officer
$3.85M
@ $203.41 · 2025-02-26
RICHMOND TIMOTHY J
Officer
$6.07M
@ $202.90 · 2025-02-26
SIATIS PERRY C.
General Counsel
$1.14M
@ $197.90 · 2025-02-20
BUCKBEE KEVIN K
Officer
$310,032
@ $172.24 · 2024-12-16
GONZALEZ RICHARD A
Officer and Director
$12.40M
@ $186.52 · 2024-08-05
Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives
ALL
2
Sells (3M)
23
Sells (12M)
Total value (12M): $65.37M
REDMOND ANDREA
Director
$451,475
@ $202.91 · 2026-06-01
PRINDIVILLE MARK Q
Former
$335,226
@ $216.27 · 2026-05-22
RIZZO MARIO
Officer of Subsidiary Company
$4.06M
@ $218.80 · 2026-05-01
WILSON THOMAS JOSEPH II
Chief Executive Officer
$3.51M
@ $208.90 · 2026-03-16
WILSON THOMAS JOSEPH II
Chief Executive Officer
$3.57M
@ $212.27 · 2026-03-02
MERTEN JESSE E
Divisional Officer
$7.09M
@ $208.57 · 2026-02-25
WILSON THOMAS JOSEPH II
Chief Executive Officer
$3.54M
@ $210.48 · 2026-02-17
WILSON THOMAS JOSEPH II
Chief Executive Officer
$3.37M
@ $200.71 · 2026-02-02
WILSON THOMAS JOSEPH II
Chief Executive Officer
$3.49M
@ $207.83 · 2026-01-12
GUPTA SUREN K
Divisional Officer
$4.11M
@ $210.00 · 2026-01-07
WILSON THOMAS JOSEPH II
Chief Executive Officer
$3.44M
@ $204.77 · 2026-01-02
WILSON THOMAS JOSEPH II
Chief Executive Officer
$3.53M
@ $210.04 · 2025-12-15
WILSON THOMAS JOSEPH II
Chief Executive Officer
$3.57M
@ $212.68 · 2025-12-01
GUPTA SUREN K
Divisional Officer
$975,751
@ $215.11 · 2025-11-28
GUPTA SUREN K
Divisional Officer
$129,010
@ $215.02 · 2025-11-24
GUPTA SUREN K
Divisional Officer
$4.71M
@ $215.21 · 2025-11-21
GUPTA SUREN K
Divisional Officer
$86,086
@ $215.22 · 2025-11-17
WILSON THOMAS JOSEPH II
Chief Executive Officer
$3.58M
@ $213.20 · 2025-11-17
GUPTA SUREN K
Divisional Officer
$301,031
@ $215.02 · 2025-11-14
WILSON THOMAS JOSEPH II
Chief Executive Officer
$3.18M
@ $189.40 · 2025-11-03
WILSON THOMAS JOSEPH II
Chief Executive Officer
$3.26M
@ $194.02 · 2025-10-20
WILSON THOMAS JOSEPH II
Chief Executive Officer
$3.53M
@ $210.19 · 2025-10-06
PRINDIVILLE MARK Q
Officer of Subsidiary Company
$1.52M
@ $206.43 · 2025-08-22
SPRIESER JUDITH A.
Director
$272,146
@ $209.34 · 2025-06-02
MERTEN JESSE E
Chief Financial Officer
$7.48M
@ $186.53 · 2025-02-10
DUGENSKE JOHN E
Divisional Officer
$6.96M
@ $191.38 · 2024-09-20
TOOHEY ROBERT
Officer
$3.01M
@ $180.17 · 2024-08-19
BRADY ELIZABETH
Officer of Subsidiary Company
$8.86M
@ $179.09 · 2024-08-16
Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives

Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives.

🎭 Mr. Market's Mood

Learn more →
ABBV
FearGreed
😏Greed(61/100)

"Market is optimistic — be cautious and ensure you have a margin of safety"

Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.
ALL
FearGreed
😏Greed(65/100)

"Market is optimistic — be cautious and ensure you have a margin of safety"

Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

Composite sentiment score based on market signals. Inspired by Buffett’s "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

⚖️ Buffett Signal

Learn more →
ABBV
Awaiting DCF Data

The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

DCF Margin of Safety: N/AMr. Market's Mood: Greed (61)
ALL
Awaiting DCF Data

The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

DCF Margin of Safety: N/AMr. Market's Mood: Greed (65)
View ABBV Full AnalysisView ALL Full Analysis

Frequently Asked Questions: ABBV vs ALL

Is AbbVie Inc. or The Allstate Corporation more undervalued in 2026?

Based on our discounted cash flow model, ALL trades at a 57.3% margin of safety (intrinsic value $618 vs. price $264), compared to ABBV's -40.7% margin of safety (intrinsic $178 vs. $251).

Which stock has a wider economic moat, AbbVie Inc. or The Allstate Corporation?

ALL scores 97/100 (Wide moat), while ABBV scores 82/100 (Wide moat). The moat score measures competitive advantage durability across ROIC consistency, margin stability, revenue predictability, and reinvestment efficiency.

Is The Allstate Corporation in financial distress?

ALL's Altman Z-Score of 1.6 places it in the Distress zone, signaling elevated bankruptcy risk. ABBV scores 2.4 (Grey zone). The Altman Z-Score is a five-factor model that predicts insolvency within two years; scores below 1.81 indicate significant distress.

Which stock has higher return on invested capital, AbbVie Inc. or The Allstate Corporation?

ABBV earns 27.6% ROIC versus ALL's 26.1%. A higher ROIC means the company generates more profit per dollar of capital employed, a hallmark of durable competitive advantage in Buffett-style analysis.

Which dividend is safer, AbbVie Inc.'s or The Allstate Corporation's?

ALL's dividend earns a safety score of 94/100 (Very Safe), compared to ABBV's 39/100 (Unsafe). ALL has raised its dividend for 3 consecutive years.

ABBV vs ALL: Which Is the Better Buy in 2026? | SafetyMargin.io